From India Ratings and Research
Marksans Pharma announced that India Ratings & Research has upgraded the company's long term issuer rating to IND A/ Positive from IND A-. The instrument-wise rating action are as under:
Fund based bank facilities - IND A/ Positive (rating upgraded)
Non fund based bank facilities - IND A1 (ratings affirmed)
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
